Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant Progression
De Smedt, Eva, Maes, Ken, Verhulst, Stefaan, Lui, Hui, Kassambara, Alboukadel, Maes, Anke, Robert, Nicolas, Heirman, Carlo, Cakana, Andrew, Hose, Dirk, Breckpot, Karine, van Grunsven, Leo A, De Veirman, Kim, Menu, Eline, Vanderkerken, Karin, Moreaux, Jérôme, De Bruyne, Elke
Published in Cancer research (Chicago, Ill.) (01.03.2018)
Published in Cancer research (Chicago, Ill.) (01.03.2018)
Get full text
Journal Article
Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions
Verheye, Emma, Bravo Melgar, Jesús, Deschoemaeker, Sofie, Raes, Geert, Maes, Anke, De Bruyne, Elke, Menu, Eline, Vanderkerken, Karin, Laoui, Damya, De Veirman, Kim
Published in International journal of molecular sciences (14.01.2022)
Published in International journal of molecular sciences (14.01.2022)
Get full text
Journal Article
Kinome expression profiling to target new therapeutic avenues in multiple myeloma
de Boussac, Hugues, Bruyer, Angélique, Jourdan, Michel, Maes, Anke, Robert, Nicolas, Gourzones, Claire, Vincent, Laure, Seckinger, Anja, Cartron, Guillaume, Hose, Dirk, De Bruyne, Elke, Kassambara, Alboukadel, Pasero, Philippe, Moreaux, Jérôme
Published in Haematologica (Roma) (01.03.2020)
Published in Haematologica (Roma) (01.03.2020)
Get full text
Journal Article
Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis
Oudaert, Inge, Satilmis, Hatice, Vlummens, Philip, De Brouwer, Wouter, Maes, Anke, Hose, Dirk, De Bruyne, Elke, Ghesquière, Bart, Vanderkerken, Karin, De Veirman, Kim, Menu, Eline
Published in Journal of experimental & clinical cancer research (01.02.2022)
Published in Journal of experimental & clinical cancer research (01.02.2022)
Get full text
Journal Article
The therapeutic potential of cell cycle targeting in multiple myeloma
Maes, Anke, Menu, Eline, Veirman, Kim De, Maes, Ken, Vand Erkerken, Karin, De Bruyne, Elke
Published in Oncotarget (27.10.2017)
Published in Oncotarget (27.10.2017)
Get full text
Journal Article
The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancers
Fan, Rong, De Beule, Nathan, Maes, Anke, De Bruyne, Elke, Menu, Eline, Vanderkerken, Karin, Maes, Ken, Breckpot, Karine, De Veirman, Kim
Published in Frontiers in immunology (11.10.2022)
Published in Frontiers in immunology (11.10.2022)
Get full text
Journal Article
The anaphase-promoting complex/cyclosome: a new promising target in diffuse large B-cell lymphoma and mantle cell lymphoma
Maes, Anke, Maes, Ken, De Raeve, Hendrik, De Smedt, Eva, Vlummens, Philip, Szablewski, Vanessa, Devin, Julie, Faict, Sylvia, De Veirman, Kim, Menu, Eline, Offner, Fritz, Spaargaren, Marcel, Moreaux, Jérôme, Vanderkerken, Karin, Van Valckenborgh, Els, De Bruyne, Elke
Published in British journal of cancer (01.06.2019)
Published in British journal of cancer (01.06.2019)
Get full text
Journal Article
Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma
Fan, Rong, Satilmis, Hatice, Vandewalle, Niels, Verheye, Emma, Vlummens, Philip, Maes, Anke, Muylaert, Catharina, De Bruyne, Elke, Menu, Eline, Evans, Holly, Chantry, Andrew, De Beule, Nathan, Hose, Dirk, Törngren, Marie, Eriksson, Helena, Vanderkerken, Karin, Maes, Ken, Breckpot, Karine, De Veirman, Kim
Published in Journal for immunotherapy of cancer (01.01.2023)
Published in Journal for immunotherapy of cancer (01.01.2023)
Get full text
Journal Article
Inhibition of the Protein Arginine Methyltransferase PRMT5 in High-Risk Multiple Myeloma as a Novel Treatment Approach
Vlummens, Philip, Verhulst, Stefaan, De Veirman, Kim, Maes, Anke, Menu, Eline, Moreaux, Jérome, De Boussac, Hugues, Robert, Nicolas, De Bruyne, Elke, Hose, Dirk, Offner, Fritz, Vanderkerken, Karin, Maes, Ken
Published in Frontiers in cell and developmental biology (08.06.2022)
Published in Frontiers in cell and developmental biology (08.06.2022)
Get full text
Journal Article
Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis
Van der Vreken, Arne, Oudaert, Inge, Ates, Gamze, Faict, Sylvia, Vlummens, Philip, Satilmis, Hatice, Fan, Rong, Maes, Anke, Massie, Ann, De Veirman, Kim, De Bruyne, Elke, Vanderkerken, Karin, Menu, Eline
Published in The Journal of pathology (01.06.2023)
Published in The Journal of pathology (01.06.2023)
Get full text
Journal Article
System Xc− inhibition blocks bone marrow-multiple myeloma exosomal crosstalk, thereby countering bortezomib resistance
Wang, Fang, Oudaert, Inge, Tu, Chenggong, Maes, Anke, Van der Vreken, Arne, Vlummens, Philip, De Bruyne, Elke, De Veirman, Kim, Wang, Yanmeng, Fan, Rong, Massie, Ann, Vanderkerken, Karin, Shang, Peng, Menu, Eline
Published in Cancer letters (01.06.2022)
Published in Cancer letters (01.06.2022)
Get full text
Journal Article
Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathway
De Veirman, Kim, Menu, Eline, Maes, Ken, De Beule, Nathan, De Smedt, Eva, Maes, Anke, Vlummens, Philip, Fostier, Karel, Kassambara, Alboukadel, Moreaux, Jérôme, Van Ginderachter, Jo A., De Bruyne, Elke, Vanderkerken, Karin, Van Valckenborgh, Els
Published in Cancer letters (01.02.2019)
Published in Cancer letters (01.02.2019)
Get full text
Journal Article
Inhibition of Oxidative Phosphorylation and Glycolysis Reduces Viability in Multiple Myeloma By Affecting mTOR-Mediated Protein Synthesis
Oudaert, Inge, Van der Vreken, Arne, Ates, Gamze, Faict, Sylvia, Vlummens, Philip, Satilmis, Hatice, Fan, Rong, Maes, Anke, De Bruyne, Elke, De Veirman, Kim, Massie, Ann, Vanderkerken, Karin, Menu, Eline
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Targeting the β 2 -adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism
Satilmis, Hatice, Verheye, Emma, Vlummens, Philip, Oudaert, Inge, Vandewalle, Niels, Fan, Rong, Knight, Jennifer M, De Beule, Nathan, Ates, Gamze, Massie, Ann, Moreaux, Jerome, Maes, Anke, De Bruyne, Elke, Vanderkerken, Karin, Menu, Eline, Sloan, Erica K, De Veirman, Kim
Published in The Journal of pathology (01.01.2023)
Published in The Journal of pathology (01.01.2023)
Get full text
Journal Article
Targeting the β 2 ‐adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism
Satilmis, Hatice, Verheye, Emma, Vlummens, Philip, Oudaert, Inge, Vandewalle, Niels, Fan, Rong, Knight, Jennifer, de Beule, Nathan, Ates, Gamze, Massie, Ann, Moreaux, Jerome, Maes, Anke, de Bruyne, Elke, Vanderkerken, Karin, Menu, Eline, Sloan, Erica, de Veirman, Kim
Published in The Journal of pathology (22.11.2022)
Published in The Journal of pathology (22.11.2022)
Get full text
Journal Article
Targeting the β2‐adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism
Satilmis, Hatice, Verheye, Emma, Vlummens, Philip, Oudaert, Inge, Vandewalle, Niels, Fan, Rong, Knight, Jennifer M, De Beule, Nathan, Ates, Gamze, Massie, Ann, Moreaux, Jerome, Maes, Anke, De Bruyne, Elke, Vanderkerken, Karin, Menu, Eline, Sloan, Erica K, De Veirman, Kim
Published in The Journal of pathology (01.01.2023)
Published in The Journal of pathology (01.01.2023)
Get full text
Journal Article